MCLR Stock Overview
A research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O).
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Medclair AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.64 |
| 52 Week High | SEK 0 |
| 52 Week Low | SEK 0 |
| Beta | 0.51 |
| 11 Month Change | -6.29% |
| 3 Month Change | -2.09% |
| 1 Year Change | 2.63% |
| 33 Year Change | -29.76% |
| 5 Year Change | n/a |
| Change since IPO | -3.53% |
Recent News & Updates
Shareholder Returns
| MCLR | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.3% | -4.8% | -1.4% |
| 1Y | 2.6% | 5.6% | 20.7% |
Return vs Industry: MCLR underperformed the Swedish Medical Equipment industry which returned 10.2% over the past year.
Return vs Market: MCLR underperformed the Swedish Market which returned 25.9% over the past year.
Price Volatility
| MCLR volatility | |
|---|---|
| MCLR Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 10.9% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: MCLR's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: MCLR's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 14 | Mikael Konig | www.medclair.com |
Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous Oxide Detector, an N2O measuring device for detecting the levels of N2O in the air. The company serves maternity wards, children’s healthcare, and dental care facilities.
Medclair AB Fundamentals Summary
| MCLR fundamental statistics | |
|---|---|
| Market cap | SEK 127.86m |
| Earnings (TTM) | SEK 2.43m |
| Revenue (TTM) | SEK 50.30m |
55.6x
P/E Ratio2.7x
P/S RatioIs MCLR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCLR income statement (TTM) | |
|---|---|
| Revenue | SEK 50.30m |
| Cost of Revenue | SEK 21.23m |
| Gross Profit | SEK 29.07m |
| Other Expenses | SEK 26.64m |
| Earnings | SEK 2.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 57.79% |
| Net Profit Margin | 4.84% |
| Debt/Equity Ratio | 0.3% |
How did MCLR perform over the long term?
See historical performance and comparison